WG Biotech ApS - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 11, 2023, WG Biotech ApS's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Director, and currently has 4,559,233 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other YMAB insiders.
Data Source: SEC.
WG Biotech ApS - Insider Non-Derivative Transactions of YMAB Common Stock
WG Biotech ApS - Insider Non-Derivative Transactions at YMAB
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 12, 2023 | P -- (Common stock) | 102863 | 7.01 | 4552778 |
| Dec 12, 2023 | P -- (Common stock) | 6455 | 6.85 | 4559233 |
| Dec 9, 2023 | P -- (Common stock) | 18503 | 6.99 | 4449915 |
| Dec 8, 2023 | P -- (Common Stock) | 6183 | 6.5 | 4431412 |
| Nov 30, 2023 | P -- (Common Stock) | 51837 | 5.97 | 4425229 |
| Nov 29, 2023 | P -- (Common Stock) | 30671 | 5.81 | 4373392 |
| Nov 28, 2023 | P -- (Common Stock) | 62516 | 5.49 | 4342721 |
| May 16, 2023 | P -- (Common Stock) | 101740 | 9.65 | 4280205 |